<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-20143" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Crouzon Syndrome</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Conrady</surname>
            <given-names>Christopher D.</given-names>
          </name>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Patel</surname>
            <given-names>Bhupendra C.</given-names>
          </name>
          <aff>University of Utah</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Christopher Conrady declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Bhupendra Patel declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>7</day>
          <month>8</month>
          <year>2023</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-20143.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>Crouzon syndrome is a genetically inherited syndrome characterized by craniosynostosis (premature fusion of coronal sutures) resulting in the skull and facial deformities. The syndrome was first described in 1912 by French physician Octave Crouzon when he identified both a mother and daughter with what was originally called &#x0201c;craniofacial dysostosis.&#x0201d; He described a triad of skull deformities, facial anomalies, and proptosis. This triad of findings was then re-labeled &#x0201c;Crouzon syndrome.&#x0201d; The syndrome&#x02019;s genetic and molecular basis has since been identified and will be discussed. The syndrome is one of many craniosynostosis syndromes and is considered to be the mildest form of them. This activity reviews the workup of Crouzon syndrome and describes the role of health professionals working together to manage this condition.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Review the clinical features of Crouzon syndrome.</p></list-item><list-item><p>Summarize the treatment of Crouzon syndrome.</p></list-item><list-item><p>Describe the differential diagnosis of Crouzon syndrome.</p></list-item><list-item><p>Outline the workup of Crouzon syndrome and describes the role of health professionals working together to manage this condition.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=20143&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=20143">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-20143.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Crouzon syndrome is a genetically inherited syndrome characterized by craniosynostosis (premature fusion of coronal sutures) resulting in the skull and facial deformities.&#x000a0;The syndrome was first described in 1912 by French physician Octave Crouzon when he identified both a mother and daughter with what was originally called &#x0201c;craniofacial dysostosis.&#x0201d; He described a triad of skull deformities, facial anomalies, and proptosis. This triad of findings was then re-labeled &#x0201c;Crouzon syndrome.&#x0201d; The syndrome&#x02019;s genetic and molecular basis has since been identified and will be discussed in more detail below. The syndrome is one of many craniosynostosis syndromes and is considered to be the mildest form of them.</p>
      </sec>
      <sec id="article-20143.s3" sec-type="Etiology">
        <title>Etiology</title>
        <p>Crouzon syndrome is inherited in an autosomal dominant pattern and is caused by a mutation in the fibroblast growth factor receptor (FGFR)-2 and -3 on chromosome 10.<xref ref-type="bibr" rid="article-20143.r1">[1]</xref><xref ref-type="bibr" rid="article-20143.r2">[2]</xref>&#x000a0; The syndrome has complete penetrance but variable expressivity resulting in phenotypically unaffected to severe deformities within the same family. In approximately 50% of cases, the mutation is the result of&#x000a0;<italic toggle="yes">de novo&#x000a0;</italic>mutations.<xref ref-type="bibr" rid="article-20143.r3">[3]</xref></p>
      </sec>
      <sec id="article-20143.s4" sec-type="Epidemiology">
        <title>Epidemiology</title>
        <p>Crouzon syndrome is a fairly rare entity and is estimated to occur in 1 in 60,000 newborns; however, it is the second most common craniosynostosis syndrome behind only the more recently described Muenke syndrome.<xref ref-type="bibr" rid="article-20143.r4">[4]</xref><xref ref-type="bibr" rid="article-20143.r5">[5]</xref></p>
      </sec>
      <sec id="article-20143.s5" sec-type="Pathophysiology">
        <title>Pathophysiology</title>
        <p>FGFR-2 and FGFR-3 are two of the four transmembrane protein receptors responsible for osteoblast differentiation during embryological development. Missense mutations in these two receptors result in gain-of-function signaling and subsequent acceleration in the differentiation of osteoblasts.<xref ref-type="bibr" rid="article-20143.r6">[6]</xref><xref ref-type="bibr" rid="article-20143.r7">[7]</xref>&#x000a0;A detailed discussion of these receptors and their downstream signaling can be found in&#x000a0;Azoury et al., 2017<italic toggle="yes">.</italic><xref ref-type="bibr" rid="article-20143.r8">[8]</xref>&#x000a0;This process results in the premature fusion of sutures. The complexity of which and why a specific suture is involved is not currently known. Depending on the sutures involved, different, abnormal patterns of growth of the skull can occur. In Crouzon syndrome brachycephaly (widened and shortened) is the most common presentation due to bi-coronal suture fusion. However, trigonocephaly (triangular) and scaphocephaly (long and narrow) are not uncommon. In the most severe cases, a &#x0201c;cloverleaf&#x0201d; skull known as a Kleeblattschadel deformity can be seen due to the closure of multiple sutures.<xref ref-type="bibr" rid="article-20143.r9">[9]</xref></p>
      </sec>
      <sec id="article-20143.s6" sec-type="History and Physical">
        <title>History and Physical</title>
        <p>Due to the autosomal inheritance pattern, family history is an important component of the history and physical. The clinical course of worsening of facial deformities over the first 1 to 2 years of life helps make the clinical diagnosis. Additional testing is usually not needed to make the diagnosis. As a genetic disease, the rest of the history of the newborn infant is unlikely to contribute much more to identifying the underlying diagnosis.&#x000a0;</p>
        <p>Crouzon syndrome is usually suspected at birth due to specific facial and cranial deformities and positive family history. There are several characteristic features of patients with Crouzon syndrome that can be seen on physical examination. The most commonly seen include brachycephaly, wide-set (hypertelorism), bulging eyes (proptosis), a flattened forehead, a beaked nose, and an underdeveloped upper jaw (maxillary/midface hypoplasia) that defines the Crouzonoid face. These patients can also suffer from a cleft lip and/or palate, hearing loss, and dental problems. The incidence of strabismus (misaligned eyes) is very&#x000a0;high. An important detail to note is the normal hands and feet found in a Crouzon patient in contrast to those with Apert syndrome, a similar but more severe craniosynostosis syndrome, where there is pronounced syndactyly of the extremities.&#x000a0;Pfeiffer syndrome, another craniosynostosis, is also epitomized by short, broad big toes and thumbs in contrast to the previously mentioned normal digits of those with Crouzon syndrome.<xref ref-type="bibr" rid="article-20143.r4">[4]</xref><xref ref-type="bibr" rid="article-20143.r10">[10]</xref></p>
      </sec>
      <sec id="article-20143.s7" sec-type="Evaluation">
        <title>Evaluation</title>
        <p>The evaluation for Crouzon syndrome is relatively straightforward in the setting of known family history as the characteristic physical examination findings confirm the diagnosis. However, in cases&#x000a0;where there is a spontaneous mutation, and the clinical presentation is not clear initially, these patients may require genetic testing for diagnosis. Additional tests in these situations may include imaging techniques such as magnetic resonance imaging (MRI) and computed tomographic (CT) imaging of the brain to detect craniosynostosis or other skeletal abnormalities. The most common imaging findings on X-ray-based techniques are perisutural sclerosis, reduced serration, and bony bridging and/or the absence of the suture altogether.<xref ref-type="bibr" rid="article-20143.r11">[11]</xref>&#x000a0;A beaten bronze appearance of the skull is also a common finding on CT in this syndrome due to multiple radiolucencies of the skull bones. These imaging modalities can also help identify sequelae of the syndrome such as radiographic findings suggestive of increased intracranial pressure that may be otherwise difficult to detect in uncooperative children.</p>
        <p>If the history, physical, and imaging are still not conclusive, molecular testing can be pursued.&#x000a0;Unfortunately, multiple craniosynostosis syndromes have a defect in one of the FGFRs; therefore, there is some&#x000a0;overlap even in their molecular pathophysiology.<xref ref-type="bibr" rid="article-20143.r8">[8]</xref>&#x000a0;For those patients that have a family history of Crouzon or one of the other craniosynostosis syndromes, prenatal genetic testing and 2-dimensional and 3-dimensional ultrasounds can be utilized to&#x000a0;confirm the diagnosis before the birth of the child.<xref ref-type="bibr" rid="article-20143.r8">[8]</xref>&#x000a0;In high-risk pregnancies, amniocentesis and/or chorionic villus sampling can be performed, but a detailed dialogue of risks and benefits must be discussed with the parents before proceeding.&#x000a0;&#x000a0;</p>
        <p>While not all required, the combination of detailed family history, specific physical examination findings, the use of various imaging modalities, and genetic testing help differentiate the spectrum of craniosynostosis syndromes (Pfeiffer, Apert, Saethre-Chotzen, Carpenter, and Jackson-Weiss syndromes) in which signs and symptoms can have significant overlap.</p>
      </sec>
      <sec id="article-20143.s8" sec-type="Treatment / Management">
        <title>Treatment / Management</title>
        <p>The management of any patient with craniosynostosis is complex and requires a team of subspecialists including pediatricians, oral maxillofacial surgeons, plastic surgeons, neurosurgeons, otorhinolaryngology (ENT) specialists, and ophthalmologists (pediatric and oculoplastics).&#x000a0;&#x000a0;Other specialists may be required depending on the specific issues at hand. Surgical management is the treatment modality of choice to correct the maldevelopment of the midface and orbits to prevent blindness and intellectual disability related to the restriction of the brain and orbital development. A detailed review of surgical techniques including the timing of repair can be seen in a recent review of the topic.<xref ref-type="bibr" rid="article-20143.r12">[12]</xref>&#x000a0;Most craniofacial surgeons currently&#x000a0;feel that single suture craniosynostosis can be repaired with only one surgery, while multiple suture craniosynostoses require a staged approach to coincide with facial growth patterns. If the cranial vault abnormalities are corrected, patients with Crouzon syndrome will have normal cognitive function, vision, hearing, and lifespans. Fortunately, not all patients will require surgery, so a team-based approach to monitoring for the development of complications related to the syndrome is necessary that would warrant intervention. The overall prognosis depends on the severity of malformations and when they were corrected.&#x000a0;Earlier correction (prior to 1 year of age) anecdotally minimizes cognitive disabilities, airway obstructions, and decreased visual acuity and results in better outcomes.<xref ref-type="bibr" rid="article-20143.r13">[13]</xref></p>
        <p>It requires long-term followup to monitor&#x000a0;ocular development&#x000a0;due to the propensity to develop strabismic amblyopia and the need for strabismus surgery. These examinations should also monitor for optic nerve edema that would raise concerns for elevated intracranial pressure. Due to airway changes, sleep apnea is also of concern. The previously mentioned team-based approach helps monitor for these vision and life-threatening complications.</p>
        <p>There is some ongoing work investigating the role of tyrosine kinase inhibitors in&#x000a0;mutated&#x000a0;<italic toggle="yes">FGFR</italic>-related craniosynostosis conditions.<xref ref-type="bibr" rid="article-20143.r14">[14]</xref>&#x000a0;Unfortunately, these studies have not been tested in humans, and are likely years away from clinical use.</p>
      </sec>
      <sec id="article-20143.s9" sec-type="Differential Diagnosis">
        <title>Differential Diagnosis</title>
        <list list-type="bullet">
          <list-item>
            <p>Apert syndrome</p>
          </list-item>
          <list-item>
            <p>Muenke&#x000a0;syndrome</p>
          </list-item>
          <list-item>
            <p>Pfeiffer syndrome</p>
          </list-item>
          <list-item>
            <p>Nonsyndromic craniosynostosis</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-20143.s10" sec-type="Prognosis">
        <title>Prognosis</title>
        <p>The prognosis of patients with Crouzon syndrome depends on early diagnosis and treatment. If treated promptly, the patients may have a near-normal lifespan.</p>
      </sec>
      <sec id="article-20143.s11" sec-type="Complications">
        <title>Complications</title>
        <list list-type="bullet">
          <list-item>
            <p>Raised intracranial pressure</p>
          </list-item>
          <list-item>
            <p>Mental subnormality</p>
          </list-item>
          <list-item>
            <p>Problems with vision</p>
          </list-item>
          <list-item>
            <p>Exposure keratitis</p>
          </list-item>
          <list-item>
            <p>Aspiration pneumonia</p>
          </list-item>
          <list-item>
            <p>Breathing problems and stridor</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-20143.s12" sec-type="Consultations">
        <title>Consultations</title>
        <list list-type="bullet">
          <list-item>
            <p>Pediatricians</p>
          </list-item>
          <list-item>
            <p>Ophthalmologists (pediatric and oculoplastics)</p>
          </list-item>
          <list-item>
            <p>Maxillofacial surgeons</p>
          </list-item>
          <list-item>
            <p>Neurosurgeons</p>
          </list-item>
          <list-item>
            <p>Plastic surgeons</p>
          </list-item>
          <list-item>
            <p>Otorhinolaryngology specialists</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-20143.s13" sec-type="Deterrence and Patient Education">
        <title>Deterrence and Patient Education</title>
        <p>The parents of the patient should be counseled about the child's condition and the expected prognosis. They should understand that they could not have done anything before or during pregnancy to prevent the birth of a baby with this condition. Genetic evaluation should be offered to the parents.</p>
      </sec>
      <sec id="article-20143.s14" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>The management of craniosynostosis is complex and difficult and requires a team of subspecialists including pediatricians, oral maxillofacial surgeons, plastic surgeons, neurosurgeons, otorhinolaryngology (ENT) specialists, and ophthalmologists (pediatric and oculoplastics). The nurses&#x000a0;involved need to be specially trained to assist in recognizing complications and educating the families. an interprofessional team approach will provide the best patient outcomes. [Level V]</p>
      </sec>
      <sec id="article-20143.s15">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=20143&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=20143">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://mdsearchlight.com/genetic-disorders/crouzon-syndrome/?utm_source=pubmedlink&#x00026;utm_campaign=MDS&#x00026;utm_content=20143">Click here for a simplified version.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/20143/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=20143">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <floats-group id="article-20143.s16">
        <fig id="article-20143.image.f1" position="float" orientation="portrait">
          <caption>
            <p>Patient with Crouzon Syndrome By Octave Crouzon - Octave Crouzon: Dysostose cranio-faciale h&#x000e9;r&#x000e9;ditaire. Bulletins et m&#x000e9;moires de la Soci&#x000e9;t&#x000e9; m&#x000e9;dicale des h&#x000f4;pitaux de Paris Vol. 33, 545-55 (1912) (http://web2.bium.univ-paris5.fr/livanc/?cote=epo0192&#x00026;do=chapitre), Public Domain, https://commons.wikimedia.org/w/index.php?curid=2049832</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="Patient_with_Crouzon_syndrome_x1912x" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <ref-list id="article-20143.s17">
        <title>References</title>
        <ref id="article-20143.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Reardon</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Winter</surname>
                <given-names>RM</given-names>
              </name>
              <name>
                <surname>Rutland</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Pulleyn</surname>
                <given-names>LJ</given-names>
              </name>
              <name>
                <surname>Jones</surname>
                <given-names>BM</given-names>
              </name>
              <name>
                <surname>Malcolm</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Mutations in the fibroblast growth factor receptor 2 gene cause Crouzon syndrome.</article-title>
            <source>Nat Genet</source>
            <year>1994</year>
            <month>Sep</month>
            <volume>8</volume>
            <issue>1</issue>
            <fpage>98</fpage>
            <page-range>98-103</page-range>
            <pub-id pub-id-type="pmid">7987400</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20143.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Meyers</surname>
                <given-names>GA</given-names>
              </name>
              <name>
                <surname>Orlow</surname>
                <given-names>SJ</given-names>
              </name>
              <name>
                <surname>Munro</surname>
                <given-names>IR</given-names>
              </name>
              <name>
                <surname>Przylepa</surname>
                <given-names>KA</given-names>
              </name>
              <name>
                <surname>Jabs</surname>
                <given-names>EW</given-names>
              </name>
            </person-group>
            <article-title>Fibroblast growth factor receptor 3 (FGFR3) transmembrane mutation in Crouzon syndrome with acanthosis nigricans.</article-title>
            <source>Nat Genet</source>
            <year>1995</year>
            <month>Dec</month>
            <volume>11</volume>
            <issue>4</issue>
            <fpage>462</fpage>
            <page-range>462-4</page-range>
            <pub-id pub-id-type="pmid">7493034</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20143.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Pal</surname>
                <given-names>US</given-names>
              </name>
              <name>
                <surname>Gupta</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Chellappa</surname>
                <given-names>AA</given-names>
              </name>
            </person-group>
            <article-title>Crouzon syndrome with primary optic nerve atrophy and normal brain functions: A case report.</article-title>
            <source>J Oral Biol Craniofac Res</source>
            <year>2012</year>
            <season>May-Aug</season>
            <volume>2</volume>
            <issue>2</issue>
            <fpage>116</fpage>
            <page-range>116-8</page-range>
            <pub-id pub-id-type="pmid">25737846</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20143.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mathijssen</surname>
                <given-names>IM</given-names>
              </name>
            </person-group>
            <article-title>Guideline for Care of Patients With the Diagnoses of Craniosynostosis: Working Group on Craniosynostosis.</article-title>
            <source>J Craniofac Surg</source>
            <year>2015</year>
            <month>Sep</month>
            <volume>26</volume>
            <issue>6</issue>
            <fpage>1735</fpage>
            <page-range>1735-807</page-range>
            <pub-id pub-id-type="pmid">26355968</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20143.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Rannan-Eliya</surname>
                <given-names>SV</given-names>
              </name>
              <name>
                <surname>Taylor</surname>
                <given-names>IB</given-names>
              </name>
              <name>
                <surname>De Heer</surname>
                <given-names>IM</given-names>
              </name>
              <name>
                <surname>Van Den Ouweland</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>Wall</surname>
                <given-names>SA</given-names>
              </name>
              <name>
                <surname>Wilkie</surname>
                <given-names>AO</given-names>
              </name>
            </person-group>
            <article-title>Paternal origin of FGFR3 mutations in Muenke-type craniosynostosis.</article-title>
            <source>Hum Genet</source>
            <year>2004</year>
            <month>Aug</month>
            <volume>115</volume>
            <issue>3</issue>
            <fpage>200</fpage>
            <page-range>200-7</page-range>
            <pub-id pub-id-type="pmid">15241680</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20143.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Di Rocco</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Biosse Duplan</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Heuz&#x000e9;</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Kaci</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Komla-Ebri</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Munnich</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Mugniery</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Benoist-Lasselin</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Legeai-Mallet</surname>
                <given-names>L</given-names>
              </name>
            </person-group>
            <article-title>FGFR3 mutation causes abnormal membranous ossification in achondroplasia.</article-title>
            <source>Hum Mol Genet</source>
            <year>2014</year>
            <month>Jun</month>
            <day>01</day>
            <volume>23</volume>
            <issue>11</issue>
            <fpage>2914</fpage>
            <page-range>2914-25</page-range>
            <pub-id pub-id-type="pmid">24419316</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20143.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Snyder-Warwick</surname>
                <given-names>AK</given-names>
              </name>
              <name>
                <surname>Perlyn</surname>
                <given-names>CA</given-names>
              </name>
              <name>
                <surname>Pan</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Yu</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Zhang</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Ornitz</surname>
                <given-names>DM</given-names>
              </name>
            </person-group>
            <article-title>Analysis of a gain-of-function FGFR2 Crouzon mutation provides evidence of loss of function activity in the etiology of cleft palate.</article-title>
            <source>Proc Natl Acad Sci U S A</source>
            <year>2010</year>
            <month>Feb</month>
            <day>09</day>
            <volume>107</volume>
            <issue>6</issue>
            <fpage>2515</fpage>
            <page-range>2515-20</page-range>
            <pub-id pub-id-type="pmid">20133659</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20143.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Azoury</surname>
                <given-names>SC</given-names>
              </name>
              <name>
                <surname>Reddy</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Shukla</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Deng</surname>
                <given-names>CX</given-names>
              </name>
            </person-group>
            <article-title>Fibroblast Growth Factor Receptor 2 (<italic>FGFR2</italic>) Mutation Related Syndromic Craniosynostosis.</article-title>
            <source>Int J Biol Sci</source>
            <year>2017</year>
            <volume>13</volume>
            <issue>12</issue>
            <fpage>1479</fpage>
            <page-range>1479-1488</page-range>
            <pub-id pub-id-type="pmid">29230096</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20143.r9">
          <label>9</label>
          <element-citation publication-type="book">
            <person-group person-group-type="author">
              <name>
                <surname>Betances</surname>
                <given-names>EM</given-names>
              </name>
              <name>
                <surname>Mendez</surname>
                <given-names>MD</given-names>
              </name>
              <name>
                <surname>Das</surname>
                <given-names>JM</given-names>
              </name>
            </person-group>
            <chapter-title>Craniosynostosis</chapter-title>
            <source>StatPearls [Internet]</source>
            <publisher-name>StatPearls Publishing</publisher-name>
            <publisher-loc>Treasure Island (FL)</publisher-loc>
            <year>2023</year>
            <month>8</month>
            <day>8</day>
            <pub-id pub-id-type="pmid">31335086</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20143.r10">
          <label>10</label>
          <element-citation publication-type="book">
            <person-group person-group-type="author">
              <name>
                <surname>Das</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Winters</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <chapter-title>Pfeiffer Syndrome</chapter-title>
            <source>StatPearls [Internet]</source>
            <publisher-name>StatPearls Publishing</publisher-name>
            <publisher-loc>Treasure Island (FL)</publisher-loc>
            <year>2023</year>
            <month>7</month>
            <day>4</day>
            <pub-id pub-id-type="pmid">30422477</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20143.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kim</surname>
                <given-names>HJ</given-names>
              </name>
              <name>
                <surname>Roh</surname>
                <given-names>HG</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>IW</given-names>
              </name>
            </person-group>
            <article-title>Craniosynostosis : Updates in Radiologic Diagnosis.</article-title>
            <source>J Korean Neurosurg Soc</source>
            <year>2016</year>
            <month>May</month>
            <volume>59</volume>
            <issue>3</issue>
            <fpage>219</fpage>
            <page-range>219-26</page-range>
            <pub-id pub-id-type="pmid">27226852</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20143.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Taylor</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Bartlett</surname>
                <given-names>SP</given-names>
              </name>
            </person-group>
            <article-title>What's New in Syndromic Craniosynostosis Surgery?</article-title>
            <source>Plast Reconstr Surg</source>
            <year>2017</year>
            <month>Jul</month>
            <volume>140</volume>
            <issue>1</issue>
            <fpage>82e</fpage>
            <page-range>82e-93e</page-range>
            <pub-id pub-id-type="pmid">28654610</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20143.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Warren</surname>
                <given-names>SM</given-names>
              </name>
              <name>
                <surname>Proctor</surname>
                <given-names>MR</given-names>
              </name>
              <name>
                <surname>Bartlett</surname>
                <given-names>SP</given-names>
              </name>
              <name>
                <surname>Blount</surname>
                <given-names>JP</given-names>
              </name>
              <name>
                <surname>Buchman</surname>
                <given-names>SR</given-names>
              </name>
              <name>
                <surname>Burnett</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Fearon</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Keating</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Muraszko</surname>
                <given-names>KM</given-names>
              </name>
              <name>
                <surname>Rogers</surname>
                <given-names>GF</given-names>
              </name>
              <name>
                <surname>Rubin</surname>
                <given-names>MS</given-names>
              </name>
              <name>
                <surname>McCarthy</surname>
                <given-names>JG</given-names>
              </name>
            </person-group>
            <article-title>Parameters of care for craniosynostosis: craniofacial and neurologic surgery perspectives.</article-title>
            <source>Plast Reconstr Surg</source>
            <year>2012</year>
            <month>Mar</month>
            <volume>129</volume>
            <issue>3</issue>
            <fpage>731</fpage>
            <page-range>731-737</page-range>
            <pub-id pub-id-type="pmid">22373978</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20143.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Carter</surname>
                <given-names>EP</given-names>
              </name>
              <name>
                <surname>Fearon</surname>
                <given-names>AE</given-names>
              </name>
              <name>
                <surname>Grose</surname>
                <given-names>RP</given-names>
              </name>
            </person-group>
            <article-title>Careless talk costs lives: fibroblast growth factor receptor signalling and the consequences of pathway malfunction.</article-title>
            <source>Trends Cell Biol</source>
            <year>2015</year>
            <month>Apr</month>
            <volume>25</volume>
            <issue>4</issue>
            <fpage>221</fpage>
            <page-range>221-33</page-range>
            <pub-id pub-id-type="pmid">25467007</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
